Jupiter Neurosciences Inc (JUNS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,062 | -8,645 | -6,070 | -3,782 | -1,529 |
| Accounts receivable | 3 | -3 | N/A | N/A | N/A |
| Other Working Capital | -190 | 109 | 496 | 560 | -145 |
| Other Operating Activity | 818 | 3,125 | 2,529 | 1,330 | 611 |
| Operating Cash Flow | $-1,432 | $-5,414 | $-3,046 | $-1,891 | $-1,063 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 5,580 | N/A | N/A | N/A |
| Debt Repayment | N/A | -146 | N/A | N/A | N/A |
| Other Financing Activity | 6 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $6 | $5,434 | $N/A | $N/A | $N/A |
| Beginning Cash Position | 3,789 | 3,770 | 3,770 | 3,770 | 3,770 |
| End Cash Position | 2,363 | 3,789 | 724 | 1,878 | 2,707 |
| Net Cash Flow | $-1,427 | $20 | $-3,046 | $-1,891 | $-1,063 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,432 | -5,414 | -3,046 | -1,891 | -1,063 |
| Free Cash Flow | -1,432 | -5,414 | -3,046 | -1,891 | -1,063 |